LivaNova Analyst Ratings
LivaNova Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/23/2023 | 25.48% | Needham | $71 → $62 | Maintains | Buy |
| 09/06/2023 | 5.24% | HSBC | → $52 | Initiates Coverage On | → Hold |
| 07/27/2023 | 25.48% | Baird | $56 → $62 | Maintains | Outperform |
| 07/27/2023 | 15.36% | Barclays | $51 → $57 | Maintains | Equal-Weight |
| 07/26/2023 | 43.7% | Needham | $63 → $71 | Reiterates | Buy → Buy |
| 07/19/2023 | 13.34% | Baird | → $56 | Initiates Coverage On | → Neutral |
| 05/08/2023 | 3.22% | Barclays | $45 → $51 | Maintains | Equal-Weight |
| 05/03/2023 | 27.5% | Needham | $77 → $63 | Maintains | Buy |
| 04/17/2023 | 55.84% | Needham | → $77 | Reiterates | → Buy |
| 04/14/2023 | -2.85% | Mizuho | → $48 | Initiates Coverage On | → Neutral |
| 04/13/2023 | -2.85% | Mizuho | → $48 | Initiates Coverage On | → Neutral |
| 12/21/2022 | 25.48% | Barclays | → $62 | Initiates Coverage On | → Equal-Weight |
| 11/23/2022 | 27.5% | Goldman Sachs | $73 → $63 | Maintains | Buy |
| 11/02/2022 | 55.84% | Needham | $88 → $77 | Maintains | Buy |
| 08/16/2022 | 47.74% | Goldman Sachs | $85 → $73 | Maintains | Buy |
| 08/04/2022 | 78.1% | Needham | $106 → $88 | Maintains | Buy |
| 05/05/2022 | 100.36% | Piper Sandler | $104 → $99 | Maintains | Overweight |
| 04/06/2022 | 92.27% | Wolfe Research | → $95 | Initiates Coverage On | → Outperform |
| 02/24/2022 | 94.29% | UBS | → $96 | Upgrades | Neutral → Buy |
| 02/24/2022 | 114.53% | Needham | $120 → $106 | Maintains | Buy |
| 12/03/2021 | 118.58% | Goldman Sachs | → $108 | Initiates Coverage On | → Buy |
| 11/03/2021 | 142.87% | Needham | $117 → $120 | Maintains | Buy |
| 08/20/2021 | 136.79% | Needham | $104 → $117 | Maintains | Buy |
| 08/17/2021 | 112.51% | Baird | $100 → $105 | Maintains | Outperform |
| 07/20/2021 | 88.22% | Needham | → $93 | Upgrades | Hold → Buy |
| 06/02/2021 | 98.34% | Piper Sandler | $99 → $98 | Maintains | Overweight |
| 04/13/2021 | 86.2% | Piper Sandler | $81 → $92 | Maintains | Overweight |
| 03/03/2021 | 70.01% | Berenberg | → $84 | Downgrades | Buy → Hold |
| 01/05/2021 | — | Needham | Downgrades | Buy → Hold | |
| 09/02/2020 | 11.31% | Baird | → $55 | Initiates Coverage On | → Outperform |
| 07/29/2020 | 37.62% | Needham | $76 → $68 | Maintains | Buy |
| 06/26/2020 | 53.82% | Needham | $84 → $76 | Maintains | Buy |
| 04/30/2020 | 1.19% | Canaccord Genuity | $66 → $50 | Maintains | Hold |
| 04/30/2020 | 15.36% | UBS | $70 → $57 | Maintains | Neutral |
| 03/24/2020 | -19.04% | Stifel | $80 → $40 | Maintains | Buy |
| 11/28/2018 | 112.51% | UBS | → $105 | Initiates Coverage On | → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/23/2023 | 25.48% | 李約瑟 | $71→$62 | 維護 | 買 |
| 09/06/2023 | 5.24% | 匯豐銀行 | →$52 | 開始承保 | →保留 |
| 07/27/2023 | 25.48% | 貝爾德 | $56→$62 | 維護 | 跑贏大盤 |
| 07/27/2023 | 15.36% | 巴克萊 | $51→$57 | 維護 | 等重 |
| 07/26/2023 | 43.7% | 李約瑟 | $63→$71 | 重申 | 購買→購買 |
| 07/19/2023 | 13.34% | 貝爾德 | →$56 | 開始承保 | →中性 |
| 05/08/2023 | 3.22% | 巴克萊 | $45→$51 | 維護 | 等重 |
| 05/03/2023 | 27.5% | 李約瑟 | $77→$63 | 維護 | 買 |
| 04/17/2023 | 55.84% | 李約瑟 | →$77 | 重申 | →購買 |
| 04/14/2023 | -2.85% | 瑞穗 | →$48 | 開始承保 | →中性 |
| 04/13/2023 | -2.85% | 瑞穗 | →$48 | 開始承保 | →中性 |
| 2022年12月21日 | 25.48% | 巴克萊 | →$62 | 開始承保 | →等重 |
| 2022年11月23日 | 27.5% | 高盛 | $73→$63 | 維護 | 買 |
| 11/02/2022 | 55.84% | 李約瑟 | $88→$77 | 維護 | 買 |
| 08/16/2022 | 47.74% | 高盛 | $85→$73 | 維護 | 買 |
| 08/04/2022 | 78.1% | 李約瑟 | $106→$88 | 維護 | 買 |
| 05/05/2022 | 100.36% | 派珀·桑德勒 | $104→$99 | 維護 | 超重 |
| 04/06/2022 | 92.27% | 沃爾夫研究 | →$95 | 開始承保 | →跑贏大盤 |
| 02/24/2022 | 94.29% | 瑞銀集團 | →$96 | 升級 | 中性→購買 |
| 02/24/2022 | 114.53% | 李約瑟 | $120→$106 | 維護 | 買 |
| 12/03/2021 | 118.58% | 高盛 | →$108 | 開始承保 | →購買 |
| 11/03/2021 | 142.87% | 李約瑟 | $117→$120 | 維護 | 買 |
| 08/20/2021 | 136.79% | 李約瑟 | $104→$117 | 維護 | 買 |
| 2021/08/17 | 112.51% | 貝爾德 | $100→$105 | 維護 | 跑贏大盤 |
| 07/20/2021 | 88.22% | 李約瑟 | →$93 | 升級 | 持有→購買 |
| 06/02/2021 | 98.34% | 派珀·桑德勒 | $99→$98 | 維護 | 超重 |
| 04/13/2021 | 86.2% | 派珀·桑德勒 | $81→$92 | 維護 | 超重 |
| 03/03/2021 | 70.01% | 貝倫伯格 | →$84 | 評級下調 | 購買→Hold |
| 01/05/2021 | - | 李約瑟 | 評級下調 | 購買→Hold | |
| 09/02/2020 | 11.31% | 貝爾德 | →$55 | 開始承保 | →跑贏大盤 |
| 07/29/2020 | 37.62% | 李約瑟 | $76→$68 | 維護 | 買 |
| 06/26/2020 | 53.82% | 李約瑟 | $84→$76 | 維護 | 買 |
| 04/30/2020 | 1.19% | 卡納科特·格納奇 | $66→$50 | 維護 | 保持 |
| 04/30/2020 | 15.36% | 瑞銀集團 | $70→$57 | 維護 | 中性 |
| 03/24/2020 | -19.04% | Stifel | $80→$40 | 維護 | 買 |
| 2018年11月28日 | 112.51% | 瑞銀集團 | →$105 | 開始承保 | →中性 |
What is the target price for LivaNova (LIVN)?
Liva Nova(Livn)的目標價格是多少？
The latest price target for LivaNova (NASDAQ: LIVN) was reported by Needham on October 23, 2023. The analyst firm set a price target for $62.00 expecting LIVN to rise to within 12 months (a possible 25.48% upside). 14 analyst firms have reported ratings in the last year.
李約瑟於2023年10月23日報道了Liva Nova(納斯達克代碼：LIVN)的最新目標價。這家分析公司將目標價定為62.00美元，預計livn將在12個月內上升(可能上漲25.48%)。過去一年，有14家分析公司公佈了評級。
What is the most recent analyst rating for LivaNova (LIVN)?
分析師對LivaNova的最新評級是多少？
The latest analyst rating for LivaNova (NASDAQ: LIVN) was provided by Needham, and LivaNova maintained their buy rating.
李艾科對Liva Nova(納斯達克代碼：LIVN)的最新分析師評級為買入，Liva Nova維持買入評級。
When is the next analyst rating going to be posted or updated for LivaNova (LIVN)?
Liva Nova(Livn)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LivaNova, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LivaNova was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與LivaNova的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。LivaNova的上一次評級是在2023年10月23日提交的，所以你應該預計下一次評級將在2024年10月23日左右的某個時候公佈。
Is the Analyst Rating LivaNova (LIVN) correct?
分析師對LivaNova(Livn)的評級正確嗎？
While ratings are subjective and will change, the latest LivaNova (LIVN) rating was a maintained with a price target of $71.00 to $62.00. The current price LivaNova (LIVN) is trading at is $49.41, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Liva Nova評級維持不變，目標價在71.00美元至62.00美元之間。LivaNova目前的股價為49.41美元，超出了分析師的預期區間。